医学
无症状的
血友病
凝血因子
因子IX
外科
内科学
儿科
作者
Devaraj Ezhilarasan,Karthik Shree Harini,Lakshmi Thangavelu
出处
期刊:Oral Oncology
[Elsevier]
日期:2022-09-01
卷期号:132: 106005-106005
被引量:1
标识
DOI:10.1016/j.oraloncology.2022.106005
摘要
Hemophilia is a hereditary disorder of coagulation that results in deficiency of factor VIII (Hemophilia A) or Factor IX (Hemophilia B) with characteristic X linked mode of inheritance, almost exclusively seen in males while females are asymptomatic carriers.The common clinical manifestation in both is prolonged bleeding on trivial trauma, mainly into larger joints or muscles. Life threatening bleeding episodes can result spontaneously or from trauma to the head or internal organs. Replacement of deficient clotting protein, known as Anti Hemophilic Factor (AHF) is the main stay in the treatment of haemophilia. Any Surgical treatment of these patients is to be planned in Institution hospital where comprehensive care is available. The availability of AHF has enabled surgeons to take up surgeries in patients with haemophilia. We discuss PWH with congenital factor VIII deficiency presented with oral squamous cell carcinoma of left side lower jaw with main aim is to provide insight into surgical management and care protocol of these patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI